Teachers Advisors’s Amneal Pharmaceuticals AMRX Stock Holding History

Teachers Advisors’s Portfolio AMRX Stock Details AMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$2.62M	Sell	184,736 -76,959	-29%	-$1.02M	﹤0.01%	1814
2018 Q4	$3.54M	Sell	261,695 -592,496	-69%	-$10.7M	0.01%	1509
2018 Q3	$19M	Buy	854,191 +97,230	+13%	+$2.05M	0.02%	747
2018 Q2	$12.4M	Buy	+756,961	New	+$13.3M	0.02%	978

Other funds holding AMRX

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

TCW Group Los Angeles, California $13.3B AUM 34.44% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Teachers Advisors's AMRX Position: Q1 2019 in Review

Teachers Advisors reduced its Amneal Pharmaceuticals (AMRX) stake by 29% in Q1 2019, selling an estimated $1.02M and leaving 184,736 shares worth $2.62M. The position accounts for ﹤0.01% of the portfolio, ranked #1814.

Teachers Advisors first reported a position in AMRX in Q2 2018 and has held it in 4 quarters since. The position peaked at $19M in Q3 2018. 164 funds tracked by Wall St. Rank hold AMRX as of Q1 2019.

Teachers Advisors held 184,736 shares of Amneal Pharmaceuticals worth $2.62M as of Q1 2019.
Teachers Advisors sold 76,959 Amneal Pharmaceuticals shares in Q1 2019, an estimated $1.02M.
Amneal Pharmaceuticals made up ﹤0.01% of Teachers Advisors's portfolio in Q1 2019, its #1814 holding.
Teachers Advisors first reported a position in Amneal Pharmaceuticals in Q2 2018 and has held it in 4 quarters since.
Teachers Advisors's Amneal Pharmaceuticals position peaked at $19M in Q3 2018.
164 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q1 2019.

Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.